myristate acetate [blood mononuclear cells (MC) and T lymphocytes] or lipopolysaccharide (monocytes)
. M C and monocytes from adult and neonatal subjects produced mRNA for GM-CSF, G-CSF, and M-CSF, whereas T cells ~roduced onlv GM-CSF mRNA. Neonatal M C and T cells I\ccumulated "only -30% as much GM-CSF mRNA as did adult MC and T cells. In contrast, the accumulation of GM-CSF mRNA by neonatal and adult monocytes was similar. Neonatal MC also accumulated similar amounts of G-CSF mRNA and somewhat more M-CSF mRNA than did adult MC; results with monocytes were similar to those with MC. Results of colony-stimulating activity bioassays on supernatants from neonatal and adult MC stimulated with concanavalin A paralleled the mRNA results. Although the overall number of colonies generated using neonatal and adult supernatants was similar, neonatal MC supernatants generated significantly more ( p < 0.05) monocyte-containing colonies (72 f 19 versus 46 f l l ) , significantly fewer ( p < 0.05) eosinophil-containing colonies (7 f 6 versus 23 f 13), and similar numbers of granulocyte-containing colonies (59 f 23 versus 63 f 11) compared with adult MC supernatants. Because GM-CSF is a major determinant of eosinophil production in these assays, these data suggested diminished amounts of GM-CSF in the neonatal culture supernatants. Similarly, GM-CSF concentrations in neonatal M C and T cell culture supernatants averaged 40 to 50% of the concentrations in adult culture supernatants as determined by ELISA ( p < 0.01). Whether the modestly diminished GM-CSF production by neonatal T cells contributes to the observed deficiency of granulocyte production in neonates, which occurs when demand is increased in response to infection, remains to be determined. (Pediatr Res 31:211-216, 1992) The human neonate is at increased risk of severe infection due to pyogenic bacteria compared with older infants and children (I). A major factor contributing to this increased susceptibility to bacterial infection is the inability of the neonate to produce adequate numbers of mature neutrophils in response to such an infection (2) (3) (4) . Circulating neutrophil precursors (CFU-GM) are elevated as much as 10-to 20-fold in the neonate (5) , and neonatal bone marrow also contains increased numbers of neutrophil precursors (6) ; however, these data do not necessarily indicate an increase in the total body pool of CFU-GM. Although it has not been possible to measure the total body pool of granulocytic precursors in the human, Christensen and Rothstein (7) estimated that 20-d gestation rats, which also have increased circulating CFU-GM, contained only about 10% as many CFU-GM per g of body weight as did adult rats. These workers also have demonstrated that, in infected human neonates, neutropenia accompanied by depletion of the neutrophil storage pool was strongly associated with a fatal outcome, whereas neutropenic patients with normal neutrophil storage pools usually survived (3) .
Neutrophil function is also impaired in the human neonate (8, 9) . Neutrophil chemotaxis is less efficient than that of adult neutrophils under a variety of conditions (10) (11) (12) (13) . Although granulocytes from healthy neonates ingest and kill bacteria about as well as those from adults under optimal conditions (14-16), when conditions are suboptimal (e.g., limiting concentrations of opsonin) or if neutrophils are obtained from sick neonates, neonatal neutrophils ingest bacteria less avidly than do adult neutrophils (reviewed in 8, 17) .
The CSF are a group of acidic glycoproteins that play an important role in the regulation of the production and function of hematopoietic cells (1 8, 19 ). These growth factors were initially identified as colony-stimulating activities that were able to sup-port the growth of hematopoietic progenitor cells in semisolid neonatal MC preparations was 49% T cells, 10% NK cells, 19% media (20) . Recently, the genes coding for several of the proteins monocytes, 17% B cells, and 3% granulocytes. Both adult and responsible for these activities have been cloned (reviewed in 18). neonatal T cell preparations contained 298% CD2+ cells and When incubated with bone marrow, GM-CSF supports the de-51% granulocytes, monocytes, or B cells. On average, adult T velopment of colonies containing cells of both granulocyte (neu-cell preparations contained 92% CD3+ cells (T cells) and 9% trophils and eosinophils) and monocyte/macrophage lineages CD 16+ cells (NK cells). The average composition of neonatal T (21) (22) (23) . GM-CSF also supports the formation of erythroid and cell preparations was similar: 87% were CD3+ (T cells) and 12% megakaryocytic colonies (23) . As their names indicate, G-CSF were CD16+ (NK cells). and M-CSF each support the development of colonies primarily Cell culture. Blood MC and T cells were cultured in conical restricted to a single lineage (24, 25) . In addition to these effects 15-mL polypropylene tubes at 5 x lo6 per mL and stimulated on proliferation and differentiation of hematopoietic precursors, with Con A (25 pg/mL) with or without PMA (50 ng/mL). the CSF have also been shown to mediate important effects on Monocytes were cultured in medium containing 20% AB serum mature cells as well (18) . For example, GM-CSF augments the in tissue culture flasks and stimulated with LPS (10 pg/mL). function of mature neutrophils, macrophages, and eosinophils, Supernatants were collected after the indicated interval, frozen including effects on the ingestion and killing of microorganisms, at -70"C, and later assayed for colony-stimulating activity and tumoricidal activity, and the production of cytokines (21, 26-for GM-CSF protein by ELISA. Preliminary experiments with 29).
MC indicated that maximal CSA and GM-CSF protein levels We hypothesized that the known deficiencies of granulocyte were detected after 48 h of stimulation; thus, the data reported production and function in the newborn could be explained, in in Tables 1 and 2 were generated from studies of supernatants part, by reduced production of colony-stimulating factors by collected at this interval. neonatal MC. We studied the expression of GM-CSF, G-CSF, RNA isolation and Northern blot analysis. Total cellular RNA and M-CSF mRNA and protein in whole MC, monocyte, and T was isolated from the cell preparations by the guanidinium lymphocyte (T cell) preparations. The results suggest that neo-isothiocyanate/cesium chloride method and quantitated spectronatal cells produce less GM-CSF, somewhat more M-CSF, and photometrically as previously described (34) . RNA was electrosimilar amounts of G-CSF compared with adult cells. Cell preparations. MC were isolated from peripheral blood of CSA assays. Bone n~arrow was aspirated from ~~o n n a l donors, healthy adult donors or umbilical cord blood of healthy term heparinized, and diluted in 5 mL supplemented NCTC 109 tissue neonates by Ficoll-Hypaque density gradient centrifugation as culture n~edium. The n~arrow was layered over Ficoll-H~~aque, previously described (30), washed twice in Hanks' balanced salt centrifuged at 400 X g for 30 min at room temperature, and the solution, resuspended, and cultured in RPMI 1640 containing 2 cells at the interface zone Were removed, washed, and mM L-gIutamine, 50 U/mL penicillin G, 50 pg/mL streptomycin pended. Cells were diluted to 1 x lo6 nucleated marrow cells/ (referred to hereafter as medium), and 5% human AB serum. mL in supplemented NCTC 109 media containing 10% FCS Monocytes were isolated from MC by adherence to plastic culture and placed in 20-mL aliquots in plastic tissue culture flasks dishes for 2 h, then nonadherent cells were removed by washing (Corning T-75, Corning NY) in a 37"C, 5% CO2 incubator for 2 eight times in PBS; such monolayers were greater than 90% h to remove monocytes. The nonadherent cells were adjusted to monocytes and less than 5% lymphocytes as described (31) . T a concentration of 5 X lo6 cells/mL and incubated with an equal cells were purified as described (32) ified by the manufacturer (One Lambda, Los Angeles, CA). The min. The buoyant cells were collected after a second Ficollcompositions of the MC and T cell preparations were assessed Hypaque centrifugation and washed; the T-depleted, phagocyteby indirect immunofluorescence microscopy and/or immunoflu-depleted bone marrow cells were diluted to a concentration of 1 orescent flow cytometry after staining as described (33) with the x lo6 cells/mL. following MAb: 9.6-CD2 (T and NK cells); 64.1-CD3 (T cells);
Final plating suspensions contained 1 x lo5 T-depleted non-2H7-Bp32 (B cells); 5F1-CDW14 (monocytes); 1GlO-CDWI5 adherent bone marrow MCImL, 20% FCS, a source of CSA (granulocytes); M21-IgG1 murine myeloma protein (negative (either 10% conditioned medium from-phytohemagglutinincontrol); and Fcl-CDI6 (NK cells). MAb 9.6, 64.1, and 2H7 stimulated MC from adults or 20% human placental-conditioned were obtained from Genetic Systems (Seattle, WA); 5F1 and medium or the experimental supernatants at 10% vol/vol), and lGlO were provided by Dr. I. Bernstein, Fred Hutchinson Cancer 0.3% agar. Recombinant human G-CSF (sp act 9.4 x 10' U/mg; Research Center, Seattle, WA. Fcl was provided by Dr. E. Clark, Amgen, Inc.,Thousand Oaks, CA) and recombinant human GMUniversity of Washington. M21 was purchased from Litton CSF (4.1 X lo6 U/mg; Genetics Institute, Cambridge, MA) Bionetics, Kensington, MD. The compositions of the adult and were used as controls in these assays. Suspensions (1 mL) were neonatal preparations were similar: the average composition of placed in 35-mm plastic Petri dishes (Lux; Lab-Tech Division, the adult MC preparations was 52% T cells, 7% NK cells, 20% Miles Laboratories, Napemille, IL), allowed to gel at room temmonocytes, 13% B cells, and 2% granulocytes and that of the perature, and placed in a 37"C, 5% COz, 100% humidity for 7 Ti*@(hpl or 2 1 d. All assays were performed in triplicate. Colonies of >50 cells were counted using an inverted microscope, and each colony was scored for the morphology of the cell type(s) it contained as previously described (38) . GM-CSF ELISA. GM-CSF protein concentrations in supernatants from adult and cord MC and T cell preparations were determined using a GM-CSF ELISA as specified by the manufacturer (Genzyme Co., Boston, MA). Dilutions of each supernatant were run in duplicate in each assay and the concentration of GM-CSF in each specimen determined by comparison with a standard curve generated by dilutions of recombinant GM-CSF.
Densitometry. The relative intensity of bands on Northern blot autoradiographs was determined using a Visage 60 densitometer with a Sun Microsystems computer (BioImage, Ann Arbor, MI). Although only a single exposure is shown in the figures, multiple exposures were obtained to ensure that the analysis was performed within the linear range of the film. Values represent the integrated intensity of the band. Results are presented as the ratio of the peak values for cells from neonates to values for cells from adults for a given probe. When total values for all time points were evaluated rather than the peak value, similar results were obtained.
Statistics. Data are expressed as mean f 1 SD. Statistical analysis was performed by a two-tailed t test, and comparison groups were considered significantly different if p < 0.05.
RESULTS

Accumulation of CSF mRNA by adult and neonatal leukocytes.
We initially compared the accumulation of the cognate mRNA for GM-CSF, G-CSF, and M-CSF in paired adult and neonatal MC preparations after stimulation with Con A (25 pg/mL), as shown by a representative Northern blot (Fig. 1) ; each lane on the filter contained a similar amount of RNA, as indicated by staining of 28s and 18s ribosomal RNA bands by methylene blue (not shown). GM-CSF mRNA accumulation by neonatal MC under these conditions was diminished in each of six experiments (by densitometry, mean = 30% of adult values; range = 12-54%). A striking peak of GM-CSF mRNA accumulation was observed at 4-6 h in the adult MC but not in neonatal MC. G-CSF mRNA accumulation was similar in the adult and neonatal MC, with some variation in kinetics noted between subjects under these conditions. M-CSF mRNA accumulation by neonatal MC was consistently greater than that by adult MC (by densitometry, mean = four times adult values; range = 2 to 7-fold). Qualitatively similar results were obtained when MC were stimulated with Con A + PMA, but the density of the bands was greater. Similar to the results with MC, when paired T-cell preparations (Fig. 2 ) from adult and neonatal subjects were stimulated with a combination of Con A (25 pg/mL) and PMA (50 ng/mL), GM-CSF mRNA accumulation by neonatal T cells was decreased, whereas EF mRNA content was similar (Fig. 2) . Overall, GM-CSF mRNA accumulation was decreased in five of six neonatal T-cell preparations (by densitometry, mean = 24% of adult values; range = 1 1-45%); in one pair, adult and neonatal T cells accumulated equivalent amounts of this message. In three additional experiments, neonatal T cells accumulated approximately one third as much GM-CSF mRNA as did adult T cells after stimulation with ionomycin (0.5 pM) plus PMA (50 ng/mL) (Fig. 2) . No accumulation of either G-CSF or M-CSF mRNA was detected in adult or neonatal T cells with either stimulus (data not shown).
The results with purified T cells suggested that they were not the source of G-CSF mRNA and M-CSF mRNA detected in the whole MC. Monocytes are likely to be the major source of these mRNA. As shown in Figure 3 , monocytes accumulated each of the three CSF mRNA when stimulated with LPS (10 pg/mL). For G-CSF mRNA and M-CSF mRNA, results with monocytes paralleled those with whole MC. Taking into account differences in loading suggested by results with the EF probe, neonatal monocytes accumulated similar amounts of GM-CSF mRNA and as much (experiment 2) or more (experiment 1) M-CSF mRNA as did adult monocytes. Interestingly, monocytes stimulated with LPS accumulated M-CSF mRNA of -4.0 and -1.8 kb (Fig. 2) , whereas MC stimulated with Con A accumulated the 1.8-kb mRNA only (Fig. 1) . In contrast to the results with whole MC and with T cells, GM-CSF mRNA accumulation by adult and neonatal monocytes was similar. This suggests that T cells are likely to have been the major source of GM-CSF mRNA detected in whole MC, although the conditions of stimulation were different.
CSA assays. Supernatants from adult and neonatal MC stimulated for 48 h with Con A alone (PMA interferes with the biologic assay) were examined for their ability to stimulate the growth of hematopoietic precursors. As shown in Table 1 , the total number of colonies generated by adult and neonatal MC supernatants was similar, but the composition of the colonies differed. Although the number of granulocyte-containing colonies was similar in both groups, neonatal MC supernatants generated significantly ( p < 0.05) more macrophage-containing colonies and significantly ( p < 0.05) fewer eosinophil-containing colonies as compared with adult MC supernatants. These data suggested increased M-CSF and diminished GM-CSF in the neonatal MC supernatants because recombinant GM-CSF generates large numbers of eosinophil-containing colonies in this assay. To confirm that GM-CSF was the principal factor contributing to the generation of eosinophil-containing colonies in these assays, we incubated aliquots of the adult and neonatal MC supernatants with an MAb to GM-CSF (39) before incubation with the bone marrow cells. This preincubation blocked the formation of -80% of the eosinophil-containing colonies by adult supernatants and 100% of the eosinophil-containing colonies generated by neonatal supernatants (data not shown). As expected, colonies containing the other cell types were less completely inhibited by preincubation of supernatants with this antibody. In adult and neonatal supernatants, neutrophil-containing colonies were inhibited by 20 and 40% and monocyte/ macrophage containing colonies were inhibited by 60 and 75%, respectively.
GM-CSF protein determinations. To confirm the differences in GM-CSF observed in the Northern analyses and CSA assays, supernatants from adult and neonatal MC and T cell preparations were collected after stimulation with either Con A alone or Con A plus PMA and assayed for GM-CSF protein by sandwich ELISA. Preliminary experiments revealed that maximum levels of GM-CSF were detected 24-48 h after stimulation, so we compared the concentrations of GM-CSF in adult and neonatal cell supernatants after this interval. As shown in Table 2 , adult MC and T cells secreted significantly ( p < 0.0 1) more GM-CSF protein than did neonatal MC and T cells. Neonatal MC stimulated with Con A secreted 42% as much GM-CSF as adult MC, while neonatal T cells stimulated with Con A plus PMA secreted 48% as much GM-CSF as adult T cells.
DISCUSSION
Our data indicate that neonatal MC, compared with adult MC, produced less than 50% as much GM-CSF as determined by colony-stimulating assays, ELISA, and RNA blot analysis. Diminished GM-CSF production by MC appeared to reflect decreased production by neonatal T cells. Neonatal T cells produced -25-50% as much GM-CSF mRNA and protein as did adult T cells, whereas neonatal and adult monocytes produced similar amounts of GM-CSF mRNA. In contrast to GM-CSF, neonatal MC produced on average 4-fold more M-CSF mRNA and supernatants of neonatal MC contained increased M-CSA compared to adult cells. G-CSF mRNA accumulation and G-CSA secretion by neonatal MC and monocytes was comparable to that of adult cells. T cells did not produce detectable M-CSF or G-CSF as determined by RNA blot analysis, consistent with previous reports (reviewed in 18, 19) .
These data provide further evidence of the immaturity of certain aspects of neonatal T lymphocyte function. Along with the diminished GM-CSF production shown in this report, neonatal T cells have an even greater impairment in the production of interferon-7 (32, 40, 41) and IL-4 (42) compared with adult T cells. This immaturity in lymphokine production is at least in part selective, inasmuch as IG2 (32, 43) and lymphotoxin (33) are produced in normal or increased amounts by neonatal T cells in vitro. Although these in vitro data cannot be assumed to reflect fully the in vivo production of cytokines by healthy or infected neonates, they suggest that reduced production of certain T cell-derived lymphokines may play a role in the increased susceptibility of neonates to infection. Unlike neonatal T cells, we found that neonatal monocytes produced as much GM-CSF, G-CSF, and M-CSF mRNA as adult monocytes. In other studies, the production of the cytokines IL-1 and tumor necrosis factor by monocytes isolated from healthy term neonates has also been equivalent to that of adult monocytes (31, 44, 45) . Thus, in contrast to T cells, diminished production of cytokines by monocytes is less likely to be a factor in the susceptibility of neonates to severe infection.
During fetal and neonatal life, circulating CFU-GM are present in numbers that exceed those in adult blood by 210-fold in humans and in rats (5, 7, 46-48) . The rate of proliferation of these circulating CFU-GM in vivo is nearly maximal (5, 48) . In addition, an increased fraction of the colonies derived from neonatal blood (when crude mixtures of CSF are used to support their growth in vitro) is composed of monocyte/macrophages (5, 49) , which parallels the relative predominance of M-CSF activity and mRNA produced by neonatal MC and monocytes in our assays. The high rate of spontaneous proliferation of CFU-GM in neonates may be due in part to increased concentrations of CSA in the blood of neonates compared with adults (48, 50) . The source of the circulating CSA is unknown. Some of this CSA is due to increased G-CSF and GM-CSF, also suggesting that monocytes may be one source. The presence of increased circulating GM-CSA suggests that the diminished capacity of neonatal T cells to produce GM-CSF is not likely to be a limiting factor in neonatal neutrophil production and release under normal conditions. It is possible that the diminished capacity of neonatal T cells to produce GM-CSF could be a factor, along with the near-maximal spontaneous rate of CFU-GM proliferation (5, 51) and the potentially diminished total body pool of CFU-GM (7), acting to limit the neonate's neutrophil production in response to infection. However, the relative importance of T cells (compared with monocytes or stromal cells) as a source of GM-CSF production in vivo remains unclear and may vary with the clinical situation.
The decreased production of GM-CSF by neonatal T cells could also contribute to the impaired function of neonatal granulocytes. Recombinant GM-CSF has been shown to enhance many functions of human neonatal neutrophils (52, 53) , including locomotion, chemotaxis, and oxidative responses. Deficiencies in the production of certain lymphokines by neonatal T cells have been implicated in the increased susceptibility of the neonate to infection. In particular, the striking reduction in interferon-y production by neonates is likely to contribute to the increased risk of neonatal infection with intracellular pathogens such as the herpesviruses, Toxoplasma, and Listeria (40) . The modestly diminished production of GM-CSF by neonatal T cells that we observed was statistically significant, but it is unclear if this difference is biologically important. Studies of the in vivo production of GM-CSF may be required to address this possibility.
